imatinib (YD312) / YD Global  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
imatinib (YD312) / YD Global
NCT03635814: The Study to YD312 Tablet in Patients With Diabetic Macular Edema

Unknown status
2a
100
US, RoW
YD312 50mg, YD312 150mg, YD312 350mg, Placebo
YD Global Life Science Co., Ltd.
Diabetic Macular Edema(DME)
07/18
03/20

Download Options